Evidence map›Paper›PMID 32585899›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Near-Infrared Rewritable, Non-Volatile Subwavelength Absorber Based on Chalcogenide Phase Change Materials.

Jianfa Zhang, Yiqiong Zhang, Qilin Hong, Wei Xu, Zhihong Zhu, Xiaodong Yuan

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. High Q Resonant SbNanomaterials (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianfa ZhangCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, China.ORCID 0000-0001-5879-5633
Yiqiong ZhangCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, China.
Qilin HongCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, China.
Wei XuCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, China.
Zhihong ZhuCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, China.
Xiaodong YuanCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, China.

Funding

Hunan Provincial Science and Technology Department 2017RS3039Hunan Provincial Science and Technology Department 2018JJ1033National Natural Science Foundation of China 11304389National Natural Science Foundation of China 11674396
6 · The paper itself

Abstract

Chalcogenide phase change materials enable the realization of novel, non-volatile, switchable electronic and photonic devices. In this paper, we propose a type of rewritable, non-volatile near infrared subwavelength absorber based on chalcogenide phase change materials. Our numerical simulations show that nearly perfect absorption more than 0.99 can be realized in the written state while the absorption of as-deposited or erased state is lower than 0.15 in the studied spectral range, leading to high contrast ratio of reflection more than 20 dB. Continuous tuning of the absorption spectra can be realized not only by varying the geometric parameters of the absorber but also by changing the crystallization ratio of the switched Ge 2 Sb 2 Te 5 (GST). The proposed device may find widespread applications in optical modulation, beam steering and so on.

Indexed as

absorberchalcogenide phase change materialsnear-infraredrewritable

Identifiers

PMID32585899
PMCPMC7353107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.